The metabolic benefits in patients with established type 2 diabetes were quite convincing, with marked improvements in fasting insulin, glucose, and HbA1c levels as well as a reduction in insulin resistance according to HOMA-IR. This evidence concerns the gene INS and Insulin resistance.